Revvity introduces new IVD reference standards for monitoring oncology diagnostic testing workflows

Revvity, Inc. has announced the launch of three Mimix^™ reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from human samples for IVD use. These cell line-derived reference standards have undergone appropriate design controls to meet U.S. Food and Drug Administration (FDA) regulatory requirements, which helps laboratories integrate them into existing workflows to support monitoring test performance, assay variation, and to help identify increases in random or systemic errors.

“Accurate diagnosis, including genomic markers, is crucial in determining which cancer treatments are likely to provide patients with the best outcomes,” said Yves Dubaquie, senior vice president, diagnostics at Revvity. “To support this, labs need quality reference standards they can trust to validate and monitor workflows. Our Mimix reference standards address that need by meeting the requirements for an IVD in the U.S.”

Offering the Mimix reference standards for IVD indicates the products have been developed and manufactured in accordance with applicable quality system requirements allowing for improved reliability and precision of these reference standards.

The three Mimix reference standards cover key cancer testing applications, which include:

• Mimix™ OncoSpan™ FFPE Reference Standard IVD (HD832-IVD)
• Mimix™ OncoSpan™ gDNA Reference Standard IVD (HD827-IVD)
• Mimix™ Myeloid Cancer Panel, gDNA Reference Standard IVD (HD829-IVD)

Leveraging 14 years of experience in developing oncology reference standards, Revvity’s Mimix controls are derived from human cell lines rather than synthetic sources, which helps maintain genomic complexity and more closely mimic patient samples.

For In Vitro Diagnostic use. These products are only available where licensed in accordance with applicable law. Please contact your local representative for availability.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>